Cellectis S.A.
CLLS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $41,506 | $755 | $19,171 | $30,346 |
| % Growth | 5,397.5% | -96.1% | -36.8% | – |
| Cost of Goods Sold | $9,182 | $7,419 | $8,484 | $1,844 |
| Gross Profit | $32,324 | -$6,664 | $10,687 | $28,502 |
| % Margin | 77.9% | -882.6% | 55.7% | 93.9% |
| R&D Expenses | $90,536 | $87,646 | $97,501 | $117,840 |
| G&A Expenses | $8,420 | $8,119 | $8,895 | $37,869 |
| SG&A Expenses | $8,420 | $8,119 | $8,895 | $22,882 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $2,709 |
| Other Operating Expenses | -$7,078 | -$5,127 | -$6,043 | -$8,739 |
| Operating Expenses | $91,878 | $90,638 | $100,353 | $131,983 |
| Operating Income | -$59,554 | -$97,302 | -$89,666 | -$103,481 |
| % Margin | -143.5% | -12,887.7% | -467.7% | -341% |
| Other Income/Exp. Net | $22,793 | -$19,162 | -$8,935 | $6,729 |
| Pre-Tax Income | -$36,761 | -$116,464 | -$98,601 | -$96,752 |
| Tax Expense | $0 | $371 | $87 | -$3 |
| Net Income | -$36,761 | -$101,059 | -$106,139 | -$114,197 |
| % Margin | -88.6% | -13,385.3% | -553.6% | -376.3% |
| EPS | -0.41 | -1.77 | -2.33 | -1.93 |
| % Growth | 76.8% | 24% | -20.7% | – |
| EPS Diluted | -0.41 | -1.77 | -2.33 | -1.93 |
| Weighted Avg Shares Out | 90,566 | 57,013 | 45,553 | 44,820 |
| Weighted Avg Shares Out Dil | 90,566 | 57,013 | 45,553 | 44,820 |
| Supplemental Information | – | – | – | – |
| Interest Income | $11,278 | $3,614 | $1,120 | $719 |
| Interest Expense | $7,453 | $5,307 | $3,787 | $4,368 |
| Depreciation & Amortization | $19,846 | $18,523 | $18,435 | $14,156 |
| EBITDA | -$9,462 | -$92,637 | -$76,378 | -$78,425 |
| % Margin | -22.8% | -12,269.8% | -398.4% | -258.4% |